The abrupt terminations of more than 1,000 employees, including new Epidemic Intelligence Officers, across CDC are deeply disturbing. For more than 70 years, EIS officers have served on America’s front line as its disease detectives, ready at a moment’s notice to respond to

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers. I have never felt so intimidated by my peers The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

The FDA fired the head of medical device safety. Devices already are barely tested, and now this agency is getting even slimmer. Oh, btw, Elon Musk’s company Neuralink has a strained relationship with the device center. Read more from Lizzy Lawrence: statnews.com/2025/02/18/fda…

NEW: Today, we launched our #BreakUpBigMedicine initiative alongside Rep. Jake Auchincloss 🟧, @BedoyaFTC, Antonio Ciaccia, doctors, small businesspeople, and patients from across the country. It's time to unite the millions of Americans who are fed up with corporate power in healthcare.👇🧵

The Trump admin appears poised to double down on one of Washington’s most entrenched orthodoxies: value-based payment (VBP) and its ideology of managed care. Andrew Ryan and I argue this is a mistake. It’s time for a new agenda in Medicare. 1/x

Please join us for the FASPE The MacLean Center joint symposium "Business and Medical Ethics: Ensuring the Primacy of Patient Care" featuring keynote speaker Dhruv Khullar - Saturday March 8th at the Gleacher Center in Chicago Registration link in the next post👇

Thrilled to contribute to this series on political economy & health. Amid growing concern about private equity & corporate medicine, we explore existing forms of public provisioning—& we argue for building on these public options as part of a post-neoliberal health agenda 1/x

How we organize our political economy shapes our health. The Institute's #HPEP team and Health Affairs Scholar are thrilled to release a new article series exploring solutions—from social insurance to community care. Explore the series: racepowerpolicy.org/hpep/health-an…

How can we rebuild our political economy to uplift the health and wellbeing of all Americans? Join us on April 1 at The New School to explore the health investments and policies, power-building strategies, and narratives we need to see real change. RSVP: bit.ly/4hHKO5q

Still wild to me that some are talking about a proposal that would increase the number of uninsured by 9.5 million (the 7.7M + 1.8M below) as moderate.

At the end of the day, your view on the House reconciliation efforts is a question of priorities. Are tax cuts, overwhelmingly for those with the highest incomes, a higher priority than health coverage for 10+ million people with the lowest incomes? washingtonpost.com/opinions/2025/…

Beautiful evening celebrating Dr. Reshma Ramachandran, recipient of The Bernard Lown Award for Social Responsibility for her work promoting equitable access to medicines, mobilizing physicians nationwide to challenge pharmaceutical industry influence, and advancing legislative reforms

Joseph Harris GlobalHealthPoliticsPodcast Amherst College Dr. Jallicia Jolly UC Davis Health Adeola Oni-Orisan Lehigh University College of Health Eduardo J. Gomez Hopkins Press Themrise Khan Daraja Press HistMedJHU Stanford Press Tim Schwab Macmillan Publishers Northwestern Anthropology Adia Benton U of MN Press UCR Political Science kim yi dionne (@dadakim.bsky.social) UC Berkeley Sociology Georgetown SFS Emily Mendenhall Vanderbilt University Press Brown University Political Science Prerna Singh Brown University School of Public Health GH-BUSPH Accountability Lab Penn Poli Sci Dept How does finance control the price and value of medicine? Joseph Harris talks to Penn Medicine's Victor Roy, MD PhD in the newest episode of the GlobalHealthPoliticsPodcast. Listen to the full episode here: …lhealthpoliticspodcast.buzzsprout.com/2364394/episod…